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Abstract
The infection caused by Trichomonas vaginalis is the most common but overlooked non-
viral sexually transmitted disease worldwide. Treatment relies on one class of drugs, the 5-
nitroimidazoles, but resistance is widespread. New drugs are urgently needed. We reported
the effect of crude and purified saponin fractions of Manilkara rufula against Trichomonas
vaginalis. The compound responsible for antitrichomonal activity was isolated and identified
as an uncommon bidesmosic saponin, Mi-saponin C. This saponin eliminated parasite via-
bility without toxicity against the human vaginal epithelial line (HMVII). In addition, the iso-
lated saponin fraction improved the metronidazole effect against a metronidazole-resistant
isolate and dramatically reduced the cytoadherence of T. vaginalis to human cells. Investi-
gation of the mechanism of death showed that the saponin fraction induced the parasite
death due to profound membrane damage, inducing a disturbance of intracellular content
without nuclear damage. To the best of our knowledge, this is the first report of antitrichomo-
nal activity in the bidesmosic saponins of Manilkara rufula.
Introduction
Trichomonas vaginalis is a parasitic protozoan that occurs in the urogenital tract and is the
causative agent of trichomoniasis, which is the most widespread non-viral sexually transmitted
disease (STD) in humans. Globally, this infection affects 276 million people per year and
increases susceptibility to HIV infection and the risk of cervical and prostate cancer [1]. The
mainstay medication for trichomoniasis is metronidazole (MTZ), but, increased cases of
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resistance are now being observed [2,3]. Therefore, efforts to identify new alternatives to con-
trol trichomoniasis are vital.
In this context, natural products are a viable alternative to synthetic drugs. From 1981 to
2014, sixty-five percent of new approved drugs for anti-parasitic treatment were natural prod-
ucts or derivatives [4] demonstrating their huge potential as a new strategy, the includes topical
treatment of vaginal infections [5]. The potential of natural products for drug discovery was
recently highlighted, which was describing their re-emergence in a new genomics era [6].
Some isolated natural products have demonstrated anti-T. vaginalis activity, such as alkaloids,
saponins, phenolics, terpenoids and polyacetylenes [7]. In addition, a polyherbal vaginal medi-
cine has been formulated with Azadirachta indica extract, purified saponins from Sapindus
mukerossi and Mentha citrate oil; this formulation showed a 100% cure rate for T. vaginalis
infection in a phase II trial, as well as for Candida albicans (77% of inhibition) and bacterial
vaginosis (68% of inhibition) [8], highlighting the capacities of extract applications.
The specie Manilkara rufula, also known as “maçaranduba”, belongs to the Sapotaceae fam-
ily. Several activities have been attributed to the Manilkara species, including antimicrobial,
anti-parasitic, and anti-cancer properties [9]. The miscellaneous activity demonstrated by the
Manilkara genus is attributed to the diversity of secondary metabolites present in these species
as triterpenoid saponins [10], triterpenes [11], flavonoids [12], and tannins [13]. However,
there are few studies regarding M. rufula, and only one study was found in the literature for
the biological effects of this plant [14], demonstrating the potential of this plant as a source of
new compounds and biological activities.
Saponins are steroid or triterpene glycosides that form stable soap-like foams in aqueous
solution due to of their amphiphilic nature, due to the linkage of isoprenoidal-derived agly-
cone to one or more sugar moieties. Saponins are also classified as monodesmosidic, bidesmo-
sidic or tridesmosidic, depending on whether one, two or three positions on the aglycone are
attached with sugar chains, respectively. They exhibit a wide variety of biological activities,
e.g., anti-inflammatory, anti-cancer, anti-bacterial, anti-fungal, antiviral, immunomodulatory,
anti-hepatotoxic, molluscicidal, antidiabetic, anti-viral, and anti-trichomonal [15–17]. In addi-
tion, monodesmosic and bidesmosic saponins have revealed significant differences in biologi-
cal activities [17].
Saponins have showen high anti-trichomonas activity, but they are still underexplored, and
few studies are reported regarding this application. The monodesmosic saponins from Hedera
colchica [18] and Buddleja madagascariensis [19] exhibited high antitrichomonas activity, as
well as the enriched fractions with monodesmosidic saponins from Passiflora alata and Quil-
laja saponaria, which were more active than the fraction of bidesmosic saponins from Ilex bra-
siliensis [15]. In addition, the fraction of saponins (monodesmosic and bidesmosic) from
Sapindus sp. [20] also demonstrated high activity, and thus, the relationship between of the
saponin structure and anti-trichomonas activity is not clear.
In this study, crude and purified saponin fractions of M. rufula were tested against T. vagi-
nalis, and the mechanism of death was investigated. In addition, constituents were identified
using LC-ESI-MS and MALDI-MS, and an uncommon bidesmosic saponin active against
trichomonas was isolated and characterized by HRMS and NMR.
Materials and methods
General procedure
MALDI-MS and MALDI-MS/MS analyses were performed using UltrafleXtreme MALDI--
TOF/TOF equipment (Bruker Daltonics, Bremen, Germany), applied in reflector positive ion
mode. Ions were accelerated at 20 kV and reaccelerated to 19 kV in the LIFT cell for MS/MS.
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Laser frequency was 1000 Hz and pulsed ion extraction was 100 ns. External calibration was
conducted using a peptide calibration standard from Bruker Daltonics. As a matrix, 2,5-dihy-
droxybenzoic acid (DHB) was used at a concentration of 20 mg/mL (4:6 of acetonitrile and
water, v/v). A 0.1 M NaCl solution was added to the mixture of matrix and sample solution (10
mg/mL), and after homogenization, 1.0 μL was placed onto a MALDI target. LC-DAD-MS anal-
yses were performed with an UFLC Shimadzu Prominence coupled to a diode array detector
(DAD) and a high resolution MicrOTOF-Q III mass spectrometer (Bruker Daltonics, Billerica,
MA, USA). A Kinetex C18 column (2.6 μm, 150 × 2.1 mm, Phenomenex) was used. The flow
rate was 0.3 mL/min, and 1.0 μL was the injection volume of the samples. The mobile phase was
composed of acetonitrile (solvent B) and deionized water (solvent A)-formic acid 0.1% (v/v).
The gradient elution profile was: 0–2 min—3% of B, 2–25 min—3–25% of B, 25–40 min—25–
80% of B; 40–43 min—80% of B. The analyses were performed at 50˚C in negative and positive
ion modes. N2 was applied as a nebulizer gas (4 Bar) and dry gas (9 L/min). The capillary voltage
was 2.5 kV. The H100 fraction was solubilized in acetonitrile and water 1:1 (v/v) at a concentra-
tion of 1.0 mg/mL, subsequently the solution was filtered (Millex 0.22 μm, PTFE, Millipore) and
injected. The 1D and 2D NMR spectra were acquired on a Bruker DRX500 spectrometer with
the deuterated solvent CD3OD (δ 3.31) used as an internal standard.
Materials
HPLC methanol, acetonitrile, trifluoroacetic acid (TFA), formic acid, and ultrapure water
(Milli-Q Millipore) were used throughout the study. Metronidazole (total impurities:
0.0005% phosphorus and0.1% insoluble matter), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT), RPMI-1640 and Dulbecco’s Modified Eagle’s Medium
(DMEM) were obtained from Sigma-Aldrich, St. Louis, MO, USA. Sephadex1 LH20 was
obtained from GE Healthcare Life Sciences. The matrix 2,5-dihydroxybenzoic acid (DHB) was
purchased from Bruker Daltonics, and NaCl was obtained from Synth.
Plant material
The leaves of M. rufula were harvested at the Parque Nacional do Catimbau (PARNA do
Catimbau), Pernambuco, Brazil (8˚37’S 37˚08’W) in February 2012 with authorization from
the Instituto Chico Mendes de Conservação da Biodiversidade (ICMBio) number SISBIO
16.806. A voucher specimen was deposited in the Herbarium of the Instituto Agronômico de
Pernambuco (IPA84889) and identified by Alexandre da Silva Gomes.
Extraction and isolation
The crude extract of M. rufula was prepared by macerating the leaves with ethanol:water [21],
and an enriched saponin fraction (H100) was obtained using a Sephadex1 LH20 column
eluted with 100% water followed by freeze-drying. A second Sephadex1 LH20 column was
performed and eluted with water, water:methanol (50:50 and 30:70), methanol, water and ace-
tone. One hundred and thirty fractions (F1-130) were obtained and analyzed by MALDI-MS.
The fractions (F23-27) were also analyzed by NMR, and Mi-saponin C (1) was structurally
identified.
Parasite cultivation
Isolates of T. vaginalis were used in the study: ATCC 30236 (JH 31A #4) and fresh clinical iso-
lates: TV-LACM2 (MTZ-sensitive), TV-LACM2R (MTZ-resistant), TV-LACM5, TV-LACM6
(high-adherent), TV-LACM11, TV-LACM22, TV-LACM24, TV-LACH4, and TV-LACH6.
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All fresh clinical isolates were obtained from Laboratório de Análises Clı́nicas e Toxicológicas,
Faculdade de Farmácia, UFRGS, Brazil, with ethical approval by the Universidade Federal do
Rio Grande do Sul (UFRGS) Research Ethical Committee (number 18923). Organisms were
cultured in TYM medium as described by Diamond [22]. Only parasites at the logarithmic
phase of growth and exhibiting motility and normal morphology were harvested, centrifuged
and resuspended in fresh TYM for assays. The parasite density of 1.0 x 105 trophozoites/mL
was used throughout the study unless stated otherwise. All experiments were performed in
triplicate with at least three independent cultures (n = 3).
Anti-Trichomonas vaginalis assays and minimum inhibitory
concentration
The anti-T. vaginalis activity of H100 and purified fractions (F10, F27, F31, F33, F35 and F113)
was performed in vitro [23]. Purified fractions were tested at 0.5 mg/mL. Trophozoite viability
was evaluated compared to untreated parasites by counting in a hemocytometer using trypan
blue dye exclusion. MIC was confirmed by the failure of non-motile parasites to grow after re-
inoculation into drug-free medium. MIC was used in the following experiments.
Kinetic growth curve
The effect of the H100 fraction on parasite growth and viability was evaluated, and a kinetic
growth curve was prepared. Parasites were treated or untreated with the H100 fraction at 0.5
mg/mL and incubated for 2, 4, 6, 12, 24, 48, 72, and 96 h. After counting using a hemocytome-
ter, the results were expressed as trophozoite number per milliliter compared to untreated
organisms.
Fluorescein diacetate and propidium iodide viability assay
Parasites were treated or untreated with the H100 fraction at 0.5 mg/mL for 2, 4, 6, 12 and 24
h. The viability of the parasites was assessed using 10 μg/mL fluorescein diacetate (FDA) and
10 μg/mL propidium iodide (PI) for 20 min before fluorescence analyses. Cytometric dot plots
were acquired using the flow cytometer FACsVerse.
Cytotoxicity against human cells
The cytotoxicity of H100 was determined using two cell lineages, HMVII (ECACC 92042701)
and HeLa (ATCC CCL-2 from BCRJ 0100) (vaginal and cervical epithelial cells, respectively).
The cells were grown and maintained as described previously [23]. Before assay, 3.0 x 104 or
1.0 x 104 cells per well were seeded in 96-well microtiter plates overnight. Then, the medium
was replaced with fresh medium containing H100 at 0.5 mg/mL. Negative (medium without
H100) and positive controls (0.2% Triton X-100) were added. The cytotoxicity was evaluated
after 24 or 48 h of incubation, and cell viability was assessed by the MTT assay.
H100 and metronidazole synergic effect
To evaluate the synergic effect of H100 and MTZ, the isolate TV-LACM2R was used. The MIC
of H100 was determined, and then TV-LACM2R was treated with 0.5 (MIC/2) and 1.0 mg/mL
H100 MIC with or without 0.0026 mg/mL (sub-lethal concentration) and 0.012 mg/mL (MIC)
MTZ. Microplates were incubated for 24 h at 37˚C and 5.0% CO2, and the viability was
assessed by hemocytometer counting.
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Cytoadherence assays
Trichomonas vaginalis (TV-LACM6) stained with CellTracker1 was treated with 0.5 mg/mL
H100 or 10 mM periodate (positive control). After treatment, stained organisms were added
to confluent cells (HeLa and HMVII) and incubated for 30 min at 37˚C and at 5% CO2. After-
wards, wells were gently washed twice with complete RPMI to remove non-attached parasites.
The attached cells were released by trypsinization and quenched with the addition of bovine
serum. After being released from the wells, the samples were analyzed by flow cytometry using
a FacsVerse cytometer.
Reactive oxygen species production
To examine whether incubation with H100-treated T. vaginalis can induce ROS production in
human neutrophils, neutrophils were isolated from the heparinized blood of healthy human
donors as described in a previous study [24] and co-incubated with or without T. vaginalis and
treated or untreated with H100 at 0.5 mg/mL, as described by Song et al. [25]. ROS generation
was evaluated by flow cytometry using a FacsVerse cytometer.
Hemolytic activity
The effect of H100 on erythrocyte membranes was evaluated as previously described [15].
Briefly, erythrocyte solution (1%) was treated with H100 and incubated for 1, 24 and 48 h at
37˚C. The supernatant absorbance was measured at 540 nm, and the hemolysis percentage was
calculated compared to a 100% hemolysis control (Triton-X 100 0.2%).
Scanning and Transmission Electron Microscopy (SEM and TEM)
The effect of the H100 fraction on T. vaginalis ultrastructure was analyzed using SEM and
TEM. Trophozoites were treated or not (control) with H100 at 0.5 mg/mL for 4 or 24 h and
them, collected by centrifugation, and fixed for 2 h 30 min with 2.5% glutaraldehyde in 0.1 M
sodium cacodylate buffer (pH 7.2). Parasites were post-fixed for 2 h in 1.0% OsO4 in 0.1 M
sodium cacodylate buffer (pH 7.2) and dehydrated in acetone. The organisms were dried to
the critical point using CO2 and coated with gold-palladium for SEM visualization [26].
Organisms were embedded in EmBed1 812-DER736 resin and ultrathin sections were cut and
stained with uranyl acetate and lead citrate for TEM visualization [27].
Statistics
Student’s t test was used for comparisons between two groups. The results are expressed as the
mean ± SD of at least three individual experiments. Statistical significance was P 0.05. Anal-
yses were performed using Statistical Package for the Social Sciences (SPSS) v.14 software.
Results and discussion
In this study, a potent in vitro effect of M. rufula against the parasite T. vaginalis was demon-
strated with an MIC of the H100 saponin fraction of 0.5 mg/mL (Fig 1A). The MIC was deter-
mined by trophozoite counting under microscopic observation with exclusion dye, which is a
laborious method. To overcome subjective counting mistakes, parasites at the MIC were inoc-
ulated in fresh TYM medium and the viability was assessed every 24 h over 120 h (5 days).
After 24 h of incubation in new medium, there was no parasite growth at 0.5 mg/mL H100,
confirming the MIC and the trichomonicidal effect, since parasite proliferation was still elimi-
nated in drug-free medium (Fig 1A, inset). The effect of H100 on parasite growth was kineti-
cally determined, and immediately after 4 h of incubation, a reduction in the parasite number
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was observed. As expected, a total elimination of parasite growth was observed after 24 h,
while the well-grown control trophozoites were highest in number at this time point (Fig 1B).
In addition, parasite viability was measured using PI-FDA labeling. Organisms with intact
membranes retain FDA dye and are assumed to be viable. In turn, trophozoites with a non-
functional membrane incorporate PI dye. As shown in S1 Fig, untreated organisms presented
only FDA labeling. H100-treated T. vaginalis displayed FDA staining; however, the reduced
parasite number was evident and confirmed using cytometric quantification analyses (S2 Fig).
Cytometry analysis agreed with the counting assays, indicating that while it is laborious,
microscopic counting is a suitable method for T. vaginalis viability and MIC determination.
The cytotoxicity of H100 to human cells was investigated for its potential against T. vagina-
lis. HMVII and HeLa cells were treated with 0.5 mg/mL H100 for 24 and 48h and then used
for the MTT viability test. H100 was not cytotoxic against HMVII and HeLa lineages, except
against HeLa after 48 h, when H100 presented low cytotoxicity (Fig 2). Importantly, this sug-
gests that H100 has selective anti-trichomonads activity and does not affect host cells.
Virulence and pathogenesis factors such as cytoadherence to epithelial cells and evasion of
the immune system may differ between long-term grown and fresh-clinical isolates [28]. The
H100 fraction was tested against eight T. vaginalis fresh-clinical isolates at 0.5 mg/mL. The
results revealed that the H100 fraction was effective against all fresh-clinical isolates, with a
reduction from 85 to 100% (Table 1). Another important result is that H100 enhanced the
growth inhibitory effects of MTZ on MTZ-resistant isolate (TV-LACM2R). Resistance to
MTZ is a growing concern, and drug resistance is expected to increase [2,3,29]. Alternatives to
avoid this public health problem are necessary. The MIC of H100 against the TV-LACM2R
isolate was 1.0 mg/mL (Fig 3A). The synergic effect of H100 and MTZ was observed when 0.5
mg/mL H100 (MIC/2) was associated with 0.0026 mg/mL MTZ (sub-lethal concentration).
Alone, 0.0026 mg/mL MTZ reduced parasite viability by approximately 50%. In turn, in asso-
ciation with H100, a significant increase in the MTZ effect was achieved with diminished of
Fig 1. Effect of the H100 fraction against Trichomonas vaginalis. MIC determination of the H100 fraction against the T. vaginalis
30236 isolate (A). Inset: MIC confirmation by counting trophozoite number after incubation on TYM fresh medium; kinetic growth curve
of H100 (0.5 mg/mL), treated trophozoite compared to control (untreated parasites) (B). Data are the mean ± SD of at least three
different experiments (parasite suspensions) performed in triplicate.
https://doi.org/10.1371/journal.pone.0188531.g001
Fig 2. Effect of the H100 fraction on viability of human HMVII and HeLa lineages at 0.5 mg/mL. Controls
represent cells in medium only, without H100. Data are the mean ± SD of at least three different experiments
performed in triplicate. *P < 0.05 versus negative control.
https://doi.org/10.1371/journal.pone.0188531.g002
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T. vaginalis viability (97% reduction) (Fig 3B). Together, these results revealed that the H100
fraction is a promising alternative against T. vaginalis for both MTZ-sensitive and MTZ–resis-
tant isolates, regardless of whether they were fresh clinical or long-term grown.
For extracellular pathogens such as T. vaginalis, the ability to adhere to the host cells is likely
a determinant factor for pathogenesis. Cytoadherence is a complex mechanism that mainly
involves surface proteins (adhesins) and glycoconjugates (lipophosphoglycan). In T. vaginalis
cytoadherence is isolate-dependent, and the adherence level is directly related to the virulence
of the isolate [28]. The T. vaginalis TV-LACM6 isolate is strongly adherent [30] and was
selected to test the effect of H100 on cytoadherence. As expected, trophozoites treated with
periodate (positive control), an agent that oxidizes surface polysaccharides such as lipopho-
sphoglycan [31], reduced cytoadherence. Importantly, the adhesion of TV-LACM6 to HMVII
and HeLa lineages was effectively reduced after H100 treatment (Fig 4), suggesting that the
H100 fraction can induce a disruption in cytoadherence.
In addition, T. vaginalis triggers interleukin-8 (CXCL8) production from neutrophils at the
infection site, and these immune cells are predominant in the vaginal discharge of patients
with trichomoniasis [32]. Reactive oxygen species (ROS) have been identified as signaling mes-
sengers, and in neutrophils, they can eliminate phagocytosed microorganisms [24]. In this
study, the effect of H100-treated T. vaginalis on ROS production by human neutrophils was
evaluated. After 30 min of stimulation, untreated and H100-treated T. vaginalis induced signif-
icant ROS production compared to non-stimulated neutrophils (Fig 5). Notwithstanding,
H100-treated trophozoites induced the same increase in ROS production as that in untreated
trophozoites, indicating that the fraction could not affect ROS production by T. vaginalis-stim-
ulated neutrophils. Organisms treated with MTZ were also unable to increase ROS production.
These data indicate that the H100 fraction, as well as MTZ, did not play an immunomodula-
tory role in ROS production by neutrophils and are in agreement with other recent studies
[33].
To evaluate the mechanism of death of T. vaginalis induced by H100, a set of experiments
was performed. The hemolytic activity of H100 was evaluated, and after 1 h of incubation,
hemolysis was not observed. In turn, H100-treated erythrocytes presented total lyses after 24
and 48 h of incubation (Table 2). Erythrocyte lysis is the most highlighted activity of saponins;
lysis may occur due to the amphiphilic nature of the compounds that interact with lipids, lead-
ing to pore formation and membrane rupture [15–17]. Saponins are secondary metabolites
with a wide spectrum of biological activities and can exhibit different activities depending on
the chemical structures, which are mainly for monodesmosic and bidesmosic [34].
Table 1. Activity of H100 against different T. vaginalis isolates. The results are expressed as trophozoite
viability (mean±SD) compared to untreated organisms (control).
Trichomonas vaginalis isolates H100 (0.5 mg/mL)
Control 100.00 ± 0.00
TVLAC-M2a 0.00 ± 0.00
TVLAC-M5 10.70 ± 1.51
TVLAC-M6 11.20 ± 1.24
TVLAC-M11 2.95 ± 1.31
TVLAC-M22 3.55 ± 0.51
TVLAC-M24 2.69 ± 1.09
TVLAC-H4 0.00 ± 0.00
TVLAC-H6 14.40 ± 2.53
aMTZ sensitive.
https://doi.org/10.1371/journal.pone.0188531.t001
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Fig 3. Combined effect of the H100 fraction and MTZ against T. vaginalis MTZ-resistant isolate. MIC
determination of the H100 fraction against T. vaginalis TV-LACM2R (A); Synergic effect of H100 and MTZ against
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The hypothesis that the H100 fraction may act on the parasite membrane was investigated
by staining H100-treated organisms with DAPI and FLUTAX-2. FLUTAX-2 is an active Taxol
fluorescent derivative and can bind and label the microtubules of intact trophozoites, allowing
accurate observation using fluorescent microscopy [35]. Our results demonstrated that un-
treated organisms (control) were intact and that microtubules were stained with FLUTAX-2,
while the nucleus was undamaged (DAPI-stained). Conversely, H100-treated trophozoites
formed clusters of debris, which were stained with FLUTAX-2, indicating the presence of
microtubules. They were not intact, and the teardrop classical morphology was disrupted but
nuclear alterations were not observed (S3 Fig).
Analyses of ultrastructural changes in T. vaginalis were performed using both SEM and
TEM. The typical morphology of untreated T. vaginalis was observed using SEM, which is
characterized as a teardrop shape, the presence of four anterior flagella, an undulating mem-
brane and axostyle (Fig 6A). Using TEM, the expected intact morphology with one nucleus,
hydrogenosomes and flagella was observed inside the trophozoites (Fig 7A and 7B). After
treatment with H100 for 4 h, process of flagella internalization began (Fig 6B), but, pseudocysts
were observed after 24 h (Fig 6C and 6D), suggesting time-dependent alteration as demon-
strated after griseofulvin treatment [36]. Parasite number was reduced substantially by com-
paring untreated and treated organisms (Fig 6 insets). In addition, changes in the intracellular
structure were also observed, such as intense cytoplasmic vacuolization, vacuoles with a mem-
branous profile, membrane rupture and an intense distribution of hydrogenosomes in the
extracellular milieu (Fig 7C–7H). Notably, after H100 treatment, the hydrogenosomes were
not aligned with the axostyle but were spread out into the cytoplasm and extracellular milieu,
indicating that the parasite membrane was affected and that all intracellular content was dis-
turbed. These data corroborated the hemolytic assay results and fluorescence microscopy, as
SEM and TEM analyses indicated that the H100 fraction mechanism of death occurred by
damaging the parasite membrane.
To identify the compounds responsible for anti-T. vaginalis activity, the H100 fraction was
purified by column chromatography yielding 130 fractions (F1-F130) and the activity was
TV-LACM2 isolate (B). *P < 0.05 versus 0.0026 mg/mL MTZ treatment. Data are the mean ± SD of at least three
different experiments (parasite suspensions) performed in triplicate.
https://doi.org/10.1371/journal.pone.0188531.g003
Fig 4. Effect of the H100 fraction on T. vaginalis TV-LACM6 isolate adhesion to HMVII and HeLa
lineages. *treatments were statistically different from control. Data are the mean ± SD of at least three
different experiments (parasite suspensions) performed in triplicate.
https://doi.org/10.1371/journal.pone.0188531.g004
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confirmed. The F10 and F113 fractions (S9 Fig) presented as the major components tannins
and flavonoids. These compounds did not reduce parasite viability, and these findings agree
with a previous study [37]. Conversely, 0.5 mg/mL F27, F31, F33, and F35 fractions totally
disrupted the trophozoite viability (Fig 8). These fractions were constituted by identified bides-
mosidic saponins (Table 3 and S10 Fig). These results corroborate our hypothesis that sapo-
nins were the active compounds responsible for M. rufula extract activity.
The structure of isolated saponin 1 (F23-F25) was identified as Mi-saponin C (Fig 9) using
1D and 2D NMR data and was confirmed using high resolution ESI mass spectrometry (S7
Fig). All spectrometric data and discussions are described in S1 and S2 Texts.
The H100 fraction was also analyzed by LC-ESI-MS to determine the presence of isobaric
saponins (S8 Fig), but the number of saponins identified by MALDI was higher than ESI, as
reported by Chapagain and Wiesman [38]. For this reason, we described in MALDI analyses
in detail (Fig 10). First, the fragmentation of Mi-saponin C (1) by MALDI-LIFT-TOF (Frac-
tions F23-F25) (Figs 10A and 11) was evaluated, and this knowledge was applied to identify
other saponins from the H100 fraction. MALDI-LIFT-TOF analyses mainly showed fragment
ions from saccharide chains, facilitating the interpretation and elucidation.
The MS/MS of Mi-saponin C (1) (m/z 1407 [M+Na]+) yielded fragment ions at m/z 741,
689, 609, 463 and 317 (Fig 10B), showing a strong predominance of the fragments produced
from the glycosidic moiety, similar to those observed for saponins, bile acids and conjugated
steroids [39]. The main fragment ions were observed at m/z 689 [M+Na-saccharide ester
chain]+ and 741 [M+Na-(aglycone+glucoside)]+, which are related to 3-O-glucopyranosyl-
Fig 5. Trichomonas vaginalis promotes ROS generation in neutrophils. Co-incubation of human
neutrophils with T. vaginalis treated with H100 and MTZ for 30 min and 10 μM DCF-DA for quantification of
ROS production. *P < 0.05 versus neutrophils alone; 5.0 mM H2O2 is a positive control.
https://doi.org/10.1371/journal.pone.0188531.g005
Table 2. Hemolytic activity of H100 at 0.5 mg/mL. The results were expressed as the percentage of erythrocytes lysis compared to positive control (Triton-
X 100 0.2%).
Hemolysis (%)
1 h 24 h 48 h
Positive control 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00
Negative control 5.52 ± 0.90 8.16 ± 1.61 19.20 ± 7.25
H100 6.13 ± 1.21 98.40 ± 9.49 111.10 ± 7.97
https://doi.org/10.1371/journal.pone.0188531.t002
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protobassic acid and the saccharide ester chain at C-28 (Fig 11), respectively; these confirmed
both parts of the saponin. Subsequently, fragment ions produced by consecutive losses of sug-
ars from m/z 741 confirmed the saccharide composition in the portion of saccharide ester
chain, such as the ions at m/z 609, 463 and 317, which are formed by the loss of a pentose
(arabinose), and then two deoxyhexoses (rhamnose). The fragmentation observed by MAL-
DI-LIFT-TOF in our study was similar to those reported for MALDI-Post Source Decay
(PSD) fragmentation, and diagnostic and sufficient ions for the identification of saponins were
visualized [39,40].
Similar fragmentation was observed for the other saponins presented in the H100 fraction,
which were identified. From the MALDI-MS spectrum of the fraction, saponins with four
(m/z 1099 [M+Na]+), five (m/z 1231, 1245 and 1261) and six saccharides (m/z 1363, 1393,
1407 and 1423) were detected; in addition, the protobassic acid linked to one sugar (m/z 689
[M+Na]+) was also detected (Fig 10B and Table 3). The fragment ion at m/z 689 was observed
for all saponins and confirmed the 3-O-hexoside protobassic acid moiety; in addition, the
Fig 6. SEM of T. vaginalis after H100 fraction treatment. A classical untreated trophozoite displaying a tear-drop shape, four anterior flagella
(AF), undulating membrane (UM) and axostyle (AX) (A); after 0.5 mg/mL H100 treatment for 4 h trophozoites displayed flagella and undulating
membrane internalization (B), and after 24 h of treatment, organisms presented a wrinkled and fissured membrane (arrow) (C). Asterisks
indicate complete flagella internalization (D).
https://doi.org/10.1371/journal.pone.0188531.g006
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Fig 7. TEM of T. vaginalis under H100 fraction treatment. Control conditions presented one nucleus (N),
hydrogenosomes (H) and anterior flagella (AF) (A-B); after 24 h of H100 treatment, trophozoites lost their
classical morphology, hydrogenosomes were found in the extracellular medium (EM), and vacuoles (V), and
arrows indicate membrane rupture (C-H).
https://doi.org/10.1371/journal.pone.0188531.g007
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saccharide ester chain was determined using the fragment ions yielded the loss of 3-O-hexo-
side protobassic acid (666 u), where the sodium ion is located.
The ion m/z 1261 produced the fragment ions m/z 689 and also the ion m/z 705, suggesting
isobaric saponin structures. The ion m/z 705 is related to the 16-hydroxyl- protobassic acid, as
confirmed by the fragment from the saccharide ester moiety (m/z 579) to determine the two
structural moieties. This triterpenic aglycone was already identified in the saponins of M. hex-
andra [41]. Thus, the sugar losses from m/z 579 confirmed these units, such as m/z 447 and
301, that were produced from the loss of a pentose and a deoxyhexose, respectively. In the
same way, twelve bidesmosic saponins were identified from the H100 fraction (Table 3), and
Fig 8. Anti-T. vaginalis activity of the purified fractions (0.5 mg/mL) from H100. Data are the mean ± SD
of at least three different experiments (parasite suspensions) performed in triplicate.
https://doi.org/10.1371/journal.pone.0188531.g008




MS/MS (m/z) MF Saponin
689.4 527.3, 357.1, 203.0pb C36H58O11 3-O-hex-protobassic acid
1099.5 689.4pb, 433.1, 301.1 C52H84O23 3-O-hex-28-O-(di-pent+deoxyhex)-protobassic acid
1231.6 689.4pb, 565.2, 433.1, 287.1 C57H92O27 3-O-hex-28-O-(tri-pent+deoxyhex)-protobassic acid
1245.6 689.4pb, 579.2, 447.1, 301.1 C58H94O27 3-O-hex-28-O-(di-pent+di-deoxyhex)-protobassic acid




1363.6 697.2pb, 689.4, 565.2, 433.1, 287.1 C62H100O31 3-O-hex-28-O-(tetra-pent+deoxyhex)-protobassic acid
1377.6 711.2pb, 689.4, 579.2, 447.1,
429.1, 301.1
C63H102O31 3-O-hex-28-O-(tri-pent+di-deoxyhex)-protobassic acid
1393.6 727.2pb, 689.4, 595.2, 463.1,
449.1, 317.1
C63H102O32 3-O-hex-28-O-(tri-pent+deoxyhex+hex)-protobassic acid
1407.6* 741.2pb, 689.4, 609.2, 463.1, 317.1 C64H104O32 3-O-β-D-glucopyranosyl-28-O-(α-L-rhamnopyranosyl-(1!3)-[β-D-glycopyranosyl-(1!4)]-β-
D-xylopyranosyl-(1!4)-α-L-rhamnopyranosyl-(1!2)-α-L-arabinopyranosyl)-protobassic
acid
1423.6 757.2, 741.2pb, 705.4, 689.4,
609.2, 595.2, 463.1, 317.1




pb: peak base; hex: hexosyl, dipent: pentosyl; deoxyhex: deoxyhexosyl.
https://doi.org/10.1371/journal.pone.0188531.t003
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their fragmentation pathways are compatible which the fragmentation of other saponins
reported in the literature [10,38–40,42,43].
Saponins have showen a potent anti-trichomonas activity, but are still underexplored, and
few studies have reported this application. This study demonstrated the potent activity of a
bidesmosic saponin from Manilkara rufula against T. vaginalis. The activity of this saponin is
higher than that presented by a fraction of bidesmosic saponins from Ilex paraguariensis, as
demonstrated in previous studies [15,44]. In addition, the fraction of monodesmosic saponins
from Sapindus sp. [20], Hedera colchica [18] and Buddleja madagascariensis [19]also exhibited
Fig 9. Chemical structure of saponin 1 isolated from Manilkara rufula.
https://doi.org/10.1371/journal.pone.0188531.g009
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high anti-trichomonas activity, showing that the relationship between the strutucture of sapo-
nins and their anti-parasitic activity is still not clear. Together, the results presented in this
study demonstrated the potential of Manilkara rufula bidesmosic saponin against T. vaginalis,
inducing parasite death due to profound membrane damage.
Fig 10. MALDI analyses of the H100 fraction. MALDI-MS of the H100 fraction (A) and MALDI-MS/MS spectra of the m/z 1407 [M+Na]+ ion
relative to saponin 1 (B) (sac: saccharide).
https://doi.org/10.1371/journal.pone.0188531.g010
Fig 11. Main fragment ions of saponin 1 obtained by MALDI-LIFT TOF.
https://doi.org/10.1371/journal.pone.0188531.g011
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